Related by context. All words. (Click for frequent words.) 75 IMA# 72 Archexin 71 BrachySil TM 70 Phase #b/#a clinical 70 mertansine 69 YONDELIS 69 trastuzumab DM1 T DM1 69 Xanafide 69 OHR/AVR# 69 StemEx R 69 vidofludimus 69 selective orally bioavailable 69 CoFactor 69 oral picoplatin 69 Personalized Immunotherapy 69 OncoVEX 69 CRMD# 69 herpetic keratitis 69 ATIR ™ 69 PSMA ADC 69 Azedra 69 Trastuzumab DM1 69 Panzem R NCD 68 Bazedoxifene 68 Pertuzumab 68 PI3K/Akt pathway inhibitor 68 Litx 68 Fludara ® 68 oral prodrug 68 budesonide foam 68 liposomal formulation 68 Phase Ib study 68 SIR Spheres 68 ruxolitinib 68 CCX# 68 Loramyc R 68 IRX 2 68 Degarelix 68 Tesetaxel 68 LEUKINE 68 ZK EPO 68 BLA filing 68 HuMax TAC 67 successfully commercialize Iluvien 67 CCR9 antagonist 67 Quinamed 67 CTAP# Capsules 67 Firazyr 67 PrevOnco ™ 67 MKC# MT 67 including eniluracil ADH 67 OncoVEX GM CSF 67 LymphoStat B TM 67 DPX Survivac 67 PANVAC VF 67 elacytarabine 67 CBLC# 67 eTag assays 67 erlotinib Tarceva ® 67 paclitaxel poliglumex 67 oncolytic virus therapies 67 octreotide implant 67 Fodosine 67 oral ridaforolimus 67 Glufosfamide 67 BrachySil 67 NADiA ProsVue 67 Civacir 67 MAGE A3 ASCI 67 regorafenib 67 Onconase 67 Phase #/#a 67 Alocrest 67 HQK 67 targeted radiotherapeutic 67 orally administered inhibitor 67 Alferon N 67 SUTENT ® 67 PROSTASCINT R 67 ATIR 67 Pemetrexed 67 investigational humanized monoclonal antibody 67 LymphoStat B belimumab 67 multi kinase inhibitor 67 acyclovir Lauriad R 67 Daclizumab 67 dasatinib Sprycel 67 Urocidin 67 Myocet 67 ENMD # 67 miconazole Lauriad ® 67 phase IIa clinical 67 Multiferon R 67 Cloretazine ® 67 XmAb# 67 AEG# 67 Elagolix 67 ELACYT 66 SPRYCEL ® 66 ocular formulation 66 docetaxel Taxotere R 66 PDE4 inhibitor 66 lomitapide 66 pertuzumab 66 immatics 66 Evoltra ® 66 ATL# [001] 66 assessing T DM1 66 Phase IIIb clinical 66 CYT# potent vascular disrupting 66 Aplidin 66 LE SN# 66 CD# antibody [001] 66 Nexavar ® 66 OvaRex ® MAb 66 MEK inhibitors 66 MyVax R 66 oral taxane 66 HuMax EGFr 66 triphendiol 66 Phase Ib II 66 personalized immunotherapy 66 JAK inhibitor 66 phase IIb clinical 66 Virulizin ® 66 GLP toxicology studies 66 immunotherapeutic vaccine 66 PHX# 66 Deforolimus 66 miRview mets 66 SYCREST 66 tiapamil 66 Vascugel 66 MKC# MKC# PP 66 Proxinium TM 66 IMC #B 66 Aflibercept 66 tanespimycin 66 VitiGam 66 TRO# 66 Oncotype DX colon cancer 66 ALN HPN 66 CINQUIL 66 OMP #M# 66 LHRH antagonist 66 ImmuKnow R 66 immunotherapeutic agent 66 PNP inhibitor 66 registrational trial 66 trastuzumab emtansine T DM1 66 trastuzumab DM1 66 rxRNA 66 Moxifloxacin 66 ZADAXIN ® 66 paclitaxel Taxol ® 66 PRT# 66 Pralatrexate 66 Peginterferon alfa 2b 66 Alvesco R 66 ospemifene 66 GVAX ® 66 ThermoDox R 66 Allovectin 7 66 Cimzia TM 66 alvespimycin 66 Shigamabs ® 66 HepaSphere 66 KSP inhibitor 66 mSEPT9 66 metastatic hormone refractory 66 preclinical efficacy 66 DermaVir Patch 66 Soliris eculizumab 66 Tezampanel 66 JAK1 66 Zingo TM 66 enzastaurin 66 ZEVALIN ® 66 EndoTAGTM 1 66 Ampligen ® 66 PEG SN# 66 Octreotide 66 metaglidasen 66 Thiarabine 66 QuadraSphere 66 Altastaph 66 Anavex #-# 66 trabectedin 65 Factor VIIa 65 Onko Sure TM 65 acyclovir Lauriad ® 65 ganetespib 65 liposomal doxorubicin 65 AKT inhibitor 65 huN# DM1 65 Panzem R 65 elotuzumab 65 CIMZIA ™ 65 sumatriptan DosePro 65 Vicinium TM 65 non nucleoside 65 Liprotamase 65 Ixempra 65 PEGylated interferon 65 TOCOSOL Camptothecin 65 5 fluorouracil leucovorin 65 corticosteroid dexamethasone 65 Metastatic Melanoma 65 anticancer compound 65 EndoTAG 65 cathepsin K inhibitor 65 OvaRex R 65 Spiegelmer ® 65 Velcade bortezomib 65 torezolid phosphate 65 Delafloxacin 65 Bendamustine 65 NAVISTAR R 65 Safinamide 65 inhaled AAT 65 Cumulase 65 Allovectin 7 r 65 TPI ASM8 65 Phase 1b clinical trials 65 Plicera 65 Ketotransdel 65 OncoGel 65 lumiliximab 65 PROLARIS 65 oral proteasome inhibitor 65 thalidomide Thalomid 65 Cloretazine 65 lexidronam injection 65 volociximab 65 Dapagliflozin 65 tolevamer 65 therapeutic monoclonal antibody 65 OvaDx 65 deforolimus 65 rALLy clinical trial 65 Sym# 65 Sopherion 65 OMNARIS HFA 65 antibody MAb 65 Urocidin TM 65 oral deforolimus 65 delafloxacin 65 EDEMA3 65 PROGENSA R 65 relapsed MM 65 selective immunoproteasome inhibitor 65 Zybrestat 65 Meets Primary Endpoint 65 Neulasta R 65 Tofacitinib 65 Trofex 65 Insegia 65 Immunotherapeutic 65 leading oral taxane 65 investigational antiplatelet agent 65 ZP# [002] 65 Silodosin 65 FOLOTYN ® 65 Vandetanib 65 ZACTIMA 65 ERYtech Pharma 65 TBC# 65 product Fentanyl TAIFUN 65 forodesine 65 anti angiogenic agent 65 Irinotecan 65 refractory chronic lymphocytic 65 Temsirolimus 65 IV Busulfex 65 Combination REOLYSIN R 65 telomerase therapeutic 65 Rigel R# 65 BRAF inhibitor 65 ChronVac C R 65 ALN TTR 65 LEVADEX ™ 65 Traficet EN 65 targeted antifolate 65 Phase III Clinical Trial 65 CINTREDEKIN BESUDOTOX 65 Ozarelix 65 DCVax ® Brain 65 BAL# [002] 65 Hepatocellular Carcinoma HCC 65 diarrhea predominant irritable 65 vinca alkaloid 65 Cleviprex TM clevidipine 65 Initiates Phase II 65 farletuzumab 65 histone deacetylase HDAC inhibitor 65 YONDELIS R 65 Carfilzomib 65 RAPAFLO 65 hoFH 65 Prodarsan R 65 SPL# Gel vaginal microbicide 65 hematological indications 65 Initiate Clinical Trial 65 Campath ® 65 Chemophase 65 Initiates Enrollment 65 oncolytic vaccine 65 Breast Cancer Assay 65 PNT# 65 EndoTAG TM -1 65 RhuDex ® 65 dasatinib Sprycel ® 65 IMiDs R 65 Campath alemtuzumab 65 MKC# 65 PDX pralatrexate 65 obatoclax 65 Hexvix ® 64 Hsp# Inhibitor 64 Exelixis compounds 64 IIa trial 64 phase IIb trial 64 Pruvel 64 preclinically 64 StemEx 64 darinaparsin ZIO 64 Solazed TM 64 thetreatment 64 IMiDs ® 64 evaluating satraplatin 64 relapsed multiple myeloma 64 Eribulin 64 PREOS R 64 Troxatyl 64 recurrent metastatic ovarian cancer 64 next generation URAT1 64 MGd 64 Panzem ® 64 Amplimexon 64 Onalta ™ 64 Xcytrin R 64 Nexavar sorafenib 64 sunitinib malate 64 Icatibant 64 pharmacokinetic PK study 64 AAG geldanamycin analog 64 Angiocept 64 Darinaparsin 64 HCV protease inhibitor 64 REMUNE R 64 PrevOnco 64 CYC# 64 axitinib 64 Tarceva TM 64 SinuNase ™ 64 trastuzumab Herceptin R 64 EpiCeram 64 anti EGFR antibody 64 Teysuno 64 novel VDA molecule 64 Ceflatonin R 64 Davanat 64 Canvaxin TM 64 Novolimus 64 Clolar ® 64 DexaSite 64 proteasome inhibitor 64 Pazopanib 64 FOLFOX6 chemotherapy regimen 64 AZILECT ® 64 Toraymyxin TM 64 ATPace TM 64 dalbavancin 64 pegylated interferons 64 MAA submission 64 Tarmogen 64 AzaSite TM 64 ProFibrix 64 2 inhibitor CYT# 64 ALN PCS 64 hypoxia selective 64 Amrubicin 64 XL# anticancer compounds 64 kidney urologic 64 cannabinor 64 IL# PE#QQR 64 BRIM2 64 neratinib 64 tigecycline 64 antiangiogenic agent 64 RLY# 64 Mipomersen 64 GALNS 64 NeuroSTAT ® 64 thymalfasin 64 XYOTAX TM 64 Ciclesonide 64 PROVENGE ® 64 PLK1 SNALP 64 OncoVex 64 VitiGam TM 64 NeuVax 64 Bezielle 64 Vidaza R 64 Biliary System 64 Phase IIb clinical trials 64 Allovectin 7 R 64 Saforis 64 radiation sensitizer 64 histone deacetylase inhibitor 64 non peptidic protease 64 Evoltra 64 pharmacodynamic effects 64 MET amplification 64 Japanese Encephalitis vaccine 64 hepatocellular cancer 64 coronary stent merged 64 Cellegesic 64 PROCHYMAL 64 Tykerb lapatinib 64 Pivotal Phase 64 Activity Assay 64 CA9 SCAN 64 CRLX# 64 Maribavir 64 PGL# 64 capecitabine Xeloda 64 LungAlert TM 64 HuMax 64 reslizumab 64 cariprazine 64 GAMMAGARD 64 OMNARIS Nasal Spray 64 virus HCV protease inhibitor 64 CR# vcMMAE 64 Yondelis ® 64 DCVax R Brain 64 Vidofludimus 64 Lixivaptan 64 Zavesca r 64 Phase IIb III 64 OraTest R 64 sapacitabine CYC# 64 candidates Azedra TM 64 treat refractory angina 64 Hemopurifier ® 64 Interferon Gamma 64 eprotirome 64 Phase lll 64 anti CD# antibodies 64 mitogen activated ERK kinase 64 tubulin inhibitor 64 EndoTAG TM 64 oxybutynin gel 64 Iluvien ® 64 registrational 64 Surfaxin LS 64 Adjuvant Treatment 64 candidate CRLX# 64 randomized controlled Phase 64 HSP# inhibitor 64 nilotinib Tasigna 64 GRNVAC1 64 CVac 64 miRview ™ mets 64 Loramyc 64 sorafenib tablets 64 MOZOBIL 64 Axiogenesis 64 GTC recombinant human 64 ONCASPAR 64 Neuromodulation System 64 Zemiva TM 64 evaluating picoplatin 64 CCX# B 64 CytoFab 64 UPLYSO 64 Qutenza TM 64 ISF# 64 galiximab 64 teriflunomide 64 SNT MC# 64 HuMax CD4 64 bevacizumab Avastin ® 63 docetaxel Taxotere ® 63 Intravenous CP 63 AMPK activators 63 Loramyc ™ 63 Erlotinib 63 Phase #b/#a trial 63 ADP receptor antagonist 63 Warfarin Coumadin 63 pan HDAC inhibitor 63 delivers fluocinolone acetonide FA 63 Oracea TM 63 ARRY # 63 Trofex TM 63 Thiovir 63 Aptocine 63 Cand5 63 SUCCEED trial 63 WILEX 63 HepeX B TM 63 vinorelbine tartrate 63 essential thrombocythemia ET 63 receptor tyrosine kinase inhibitor 63 indibulin 63 Ridaforolimus 63 JAK2 Inhibitor 63 investigational immunotherapy 63 IAP inhibitor 63 vemurafenib 63 NADiA 63 urocortin 2 63 SEPET TM 63 RhuDex TM 63 p# biomarker 63 PROMUS TM 63 metastatic CRC 63 PTK# 63 R#/MEM # 63 tramiprosate Alzhemed TM 63 malignant ascites 63 RNAi therapeutic targeting 63 AzaSite Plus 63 Natalizumab 63 APTIVUS 63 Microwave Ablation System 63 LE DT 63 Dacogen injection 63 Bayer HealthCare Onyx Pharmaceuticals 63 novel histone deacetylase 63 Allovectin 7 ® 63 OGeS 63 NEBIDO 63 catheter occlusion 63 sorafenib Nexavar 63 Zemiva ™ 63 lorvotuzumab mertansine 63 luteinizing hormone releasing 63 agonistic human 63 favorable pharmacokinetic profile 63 MORAb 63 Dalbavancin 63 Alferon LDO 63 metastatic colorectal 63 zanolimumab 63 Vascular Wrap TM 63 vascular disrupting agents 63 candidate TNFerade biologic 63 HuLuc# 63 NEUMUNE 63 samalizumab 63 HuMax CD#b 63 nucleotide analog 63 MT#/MEDI-# 63 echinocandin 63 TEMODAL 63 miRview TM mets 63 eniluracil 63 Therapeutic Vaccine 63 anticoagulant reversing agent 63 Epratuzumab 63 TG# [003] 63 Septin9 biomarker 63 Crofelemer budesonide foam 63 DCVax R 63 oral antiviral 63 Triapine 63 Pivotal Study 63 Deferiprone 63 RIGScan CR 63 Annamycin 63 oxaliplatin Eloxatin 63 drug ISA# 63 NVA# 63 Hedgehog Pathway Inhibitor 63 EGS# 63 cellular immunotherapy 63 Panzem 63 Dasatinib 63 Lenocta 63 LHRH antagonists 63 INTEGRILIN ® 63 VeriStrat 63 Lovaxin C 63 IND submission 63 Oncotype 63 Novosom 63 CLORETAZINE TM VNP#M 63 hypoxia activated prodrug 63 LibiGel ® 63 VEGFR2 inhibitor 63 EFAPROXYN 63 Mepact 63 Aptivus ® 63 Solazed 63 cancer immunotherapies 63 Anturol TM 63 Completes Patient Enrollment 63 docetaxel Taxotere 63 generation purine nucleoside 63 ILUVIEN ® 63 Symadex 63 P#X# antagonist 63 cetuximab Erbitux R 63 compound INCB# 63 Aryplase 63 Interferon beta 1a 63 L BLP# 63 Onalta TM 63 ® bortezomib 63 Angiolix 63 IGF 1R inhibitor 63 Zorbtive TM 63 Hormone Refractory Prostate Cancer 63 liposomal amphotericin B 63 Pivotal Phase III 63 Actemra tocilizumab 63 Thrombin 63 entinostat 63 IMPDH inhibitor 63 small molecule tyrosine 63 Fibrin Pad 63 riociguat 63 FavId 63 Onalta 63 TEMSO 63 myelofibrosis polycythemia vera 63 MYDICAR ® 63 Receives Orphan Drug Designation 63 GSK '# 63 vorinostat 63 Interferon alpha 63 ADVIA Centaur XP 63 Achieves Primary Endpoint 63 investigational monoclonal antibody 63 antibody MT# 63 Imprime PGG 63 Initiate Phase 63 Prolongs Survival 63 Cloretazine VNP#M 63 HGS# 63 personalized cellular immunotherapy 63 huC# DM4 63 DAVANAT 63 Gastrointestinal Stromal Tumors 63 K RAS 63 Aliskiren 63 sargramostim 63 TransVax TM 63 PRTX 63 histamine dihydrochloride 63 pitavastatin 63 accumulate preferentially 63 Aloxi injection 63 Axentis Pharma 63 CIMZIA TM 63 beta 1a 63 INT# [002] 63 omega interferon 63 Inhalation Solution 63 5 HT3 antagonist 63 epigenetic therapies 63 Ceflatonin 63 induced macular edema 63 DNA methylation biomarkers 63 Zysolin TM 63 TAXUS Element Stent System 63 acetonide FA 63 FUSILEV ® 63 Epirubicin 63 BRAF inhibitors 63 G#DT 63 bendamustine HCl 63 Triapine R 63 bardoxolone 63 vapreotide acetate 63 cutaneous T 63 adult mesenchymal stem 63 MGN# 63 SinuNase TM 63 ixabepilone 63 depsipeptide 63 CDP# 63 Cinacalcet HCl 63 Microspheres 63 ProSavin 63 HyperAcute 63 Erbitux cetuximab 63 AEGR 63 Pivotal Trial 63 ALN TTR# 63 Corus CAD 63 Kamada AAT 63 multicenter Phase II 63 seliciclib CYC# 63 Panitumumab 63 dose escalation Phase 63 Exelixis XL# 63 Arno Therapeutics 63 monoclonal antibody therapeutics 63 mTOR inhibitor 63 Increlex R 63 Rescula 63 MEK Inhibitor 63 ponatinib 63 OMAPRO 63 INCB# [001] 63 Ceftaroline 63 subcutaneous formulation 63 Xeloda ® 63 pexiganan 63 pharmacokinetic equivalence 63 Epigenomics proprietary 63 BEXXAR 63 amifampridine phosphate 63 Solorel TM 63 torezolid 63 PathFinderTG 63 oral rivaroxaban 63 nasal decolonization 63 POTELLIGENT ® 63 Gemcitabine 63 Trobalt 63 Genz # 63 Vicriviroc 63 vosaroxin 63 Nivestim 63 autologous cellular immunotherapy 63 candidate deforolimus 63 CEQ# 63 MEK inhibitor RDEA# 63 P2V TM 63 Phase Ib IIa 63 phase IIa 63 BAY #-# 63 ProtAffin 63 ularitide 63 ongoing Phase 1b 63 BioGlue ® 63 intravesical infusion therapy 63 vascular disrupting agent 63 By JENNIFER LEARN 63 cilengitide 63 Glatiramer Acetate 63 Granulocyte Colony Stimulating Factor 63 adecatumumab 63 mapatumumab 63 NEBIDO R 63 monoclonal antibody conjugated 63 phase Ib clinical 63 SynCon 63 XmAb 63 ATPace 63 Varespladib 63 TRISENOX 63 Optical Biopsy System 63 Vectibix panitumumab 63 Genasense ® oblimersen 63 Micromet BiTE 63 Phase IIb Trial 63 Epanova 63 dose escalation clinical 63 Advaxis Phase 63 Neuvenge 63 VALSTAR 63 APEX PD 63 VERSANT 63 oral FTY# 63 IMGN# 63 MabCampath 63 PROVENGE sipuleucel T 62 antiangiogenic agents 62 #I TM# 62 RNAi therapeutic targeting PCSK9 62 therapeutic monoclonal antibodies 62 drug pipeline TAFA# 62 CXA 62 HCV NS5B polymerase 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 Pafuramidine 62 Solasia 62 Capesaris 62 relapsing remitting MS RRMS 62 CCR5 receptor antagonist 62 APTIMA HPV assay 62 Tesmilifene 62 tesmilifene 62 HDL Selective Delipidation 62 BENLYSTA ® 62 orally dosed 62 Zalypsis 62 DEB# 62 Microplasmin 62 pegylated liposomal doxorubicin 62 Phase IIb trials 62 Trastuzumab 62 Monoclonal antibody 62 Embosphere Microspheres 62 PF # [002] 62 Randomized Phase II 62 Dacogen decitabine 62 fluoropyrimidine 62 Octreolin 62 Kepivance 62 Revlimid lenalidomide 62 Phase 2b Clinical Trial 62 AtherOx 62 Tumour Vascular Disrupting Agent 62 Gentamicin Surgical Implant 62 PROSTVAC TM 62 RECOTHROM R 62 Pirfenidone 62 Lucanix R 62 RezularTM 62 ImmunoGen TAP technology 62 ALVESCO ® 62 cystinosis patients 62 confirmatory Phase III 62 pain palliation 62 IONSYS TM 62 MicroThermX 62 ATL# [002] 62 ToGA 62 bendamustine 62 Phase #/#a trial 62 Exherin TM 62 ALGRX 62 deCODE ProstateCancer TM 62 Opterone R 62 CytoFabTM 62 R sorafenib tablets 62 Onko Sure ® 62 INCB# [002] 62 Ocrelizumab 62 topoisomerase II inhibitor 62 Anticalin R 62 Virulizin R 62 humanized anti 62 IMiD 62 TransMID TM 62 hereditary deficiency 62 topically applied SEPA 62 Tovaxin TM 62 Oral NKTR 62 UroVysion 62 methylnaltrexone bromide 62 Certican 62 Taxotere ® 62 hormone LHRH antagonist 62 MAbs 62 investigational therapies 62 Kuvan R 62 Ophena 62 Tamibarotene 62 GVAX R 62 Septin 9 62 Clinical Trial Investigating REOLYSIN 62 Golimumab 62 AVASTIN 62 Nanobody R 62 Neuradiab 62 Gleevec imatinib mesylate 62 ketolide antibiotic 62 cediranib 62 CLIRS trial 62 PSN# [001] 62 Kiadis Pharma 62 pomalidomide 62 Squalamine 62 Ophena TM 62 Dyloject TM 62 Phase 2a trial 62 TMC# [002] 62 Lenalidomide 62 VISICOL R 62 HepeX B 62 OnDose 62 multiple myeloma MM 62 OMAPRO ™ 62 Sphingomab TM 62 evaluating tivozanib 62 anti CD3 62 Alzhemed TM 62 malignant pleural mesothelioma 62 PROMUS Element Stent 62 elvucitabine 62 Chemoradiation 62 LAB CGRP 62 Zenpep 62 markets HP Acthar 62 ZOLINZA 62 novel therapeutic antibodies 62 cancer neuroendocrine tumor 62 Metastatic Colorectal Cancer 62 First Patient Dosed 62 BHT DNA 62 TroVax ® 62 recombinant FVIII 62 DU #b 62 Onrigin 62 Mycophenolate Mofetil 62 BLA submission 62 Cetrorelix 62 PEGylated Fab fragment 62 Zirgan 62 THR beta agonist 62 product candidate Lpathomab 62 IMiDs ® compound 62 PEG interferon 62 TKM ApoB 62 metastatic castration resistant 62 Phase 1b clinical 62 Acute Ischemic Stroke 62 delipidation 62 Diabetic Macular Edema 62 Preotact 62 DXL TM 62 interferon gamma 1b 62 daptomycin 62 lintuzumab SGN 62 Zemplar Capsules 62 Zenvia ™ 62 Targretin capsules 62 Actimmune ® 62 CCR5 antagonist 62 plasma kallikrein inhibitor 62 phase IIb study 62 HCV protease inhibitors 62 KIACTA ™ 62 Afatinib 62 SYGNIS 62 Iluvien TM 62 Elocalcitol 62 Diamyd ® 62 photoprotective drug 62 OLEPTRO 62 liver resection surgeries 62 novel nucleoside analog 62 DOS# 62 evaluating mipomersen 62 TransVax tm 62 tyrosine kinase inhibitor TKI 62 COBAS R 62 Hexvix 62 recurrent NSCLC 62 Unresectable 62 JAK2 inhibitors 62 MyVax ® 62 Gleevec resistant 62 EOquin TM 62 REMINYL ® 62 nosocomial pneumonia 62 hormone refractory 62 Locteron ® 62 TRIST study 62 orally bioavailable mimics 62 bavituximab monotherapy trial 62 DepoVax TM 62 Onko Sure ™ 62 oritavancin semi 62 trastuzumab Herceptin 62 NOX E# 62 AlloDerm R 62 Aviptadil 62 Apaziquone 62 CYT# QbG# 62 Talabostat 62 GW# [003] 62 Anticalin ® 62 glucokinase activator 62 doxorubicin Transdrug ® 62 Prednisporin TM 62 Advanced Renal Cell 62 rilonacept 62 OmniWave 62 Fibrillex TM 62 refractory prostate cancer 62 A1PI 62 velafermin 62 OMP #R# 62 progressive metastatic prostate 62 Ceplene/IL-2 62 Gamunex C 62 ofatumumab HuMax CD# 62 cangrelor 62 anti CD# monoclonal 62 metastatic HRPC 62 DCVax Brain 62 Argatroban 62 resminostat 62 Eniluracil 62 XL# XL# 62 Onco TCS 62 CD# monoclonal antibody 62 BR.# 62 Metvix 62 biologic therapeutics